Panitumumab
ACCRU-GI-1623
Phase 2 mab active
Quick answer
Panitumumab for Metastatic Colon Adenocarcinoma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Metastatic Colon Adenocarcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active